引用次数
引用: 33,922
H-指数: 89
I10-指数 : 352
出版物: 699
Artificial intelligence driven de novo molecular design for nuclear receptor ligand discovery
D Merk , L Friedrich , G Schneider , F Grisoni
Annual Meeting of the German Pharmaceutical Society – DPhG Pharmaceutical Science: Structure, Function and Application
2018
Distinct roles of HtrA proteases from different Gram-negative bacteria in cleaving the junctional protein and tumor suppressor E-cadherin
S Backert , F Ferreira , N Sewald , P Briza
Journal of Biological Chemistry 10115 -10120
2012
Depressivität – Screening und Vorkommen in der sportmedizinischen Praxis
A Spengler , G Schneider , EP Schröder
Deutsche Zeitschrift Fur Sportmedizin 2013 ( 02) 65 -68
4
2013
Boswellic acids from the anti-inflammatory remedy frankincense: Identification and functional analysis of novel molecular targets within the arachidonic acid cascacde
U Siemoneit , F Dehm , B Hofmann , N Kather
Planta Medica 74 ( 09)
2008
Computational approaches to natural products-based lead discovery
G Schneider
Planta Medica 81 ( 16)
2015
Peptide lineup against Gram-negative bacterial infection – first-in-class peptide inhibitor of H. pylori HtrA
Anna M Perna , Thomas Schmidt , Tim Fugmann , Nicole Tegtmeyer
Journal of Cheminformatics 6 ( 1) 46
2014
Visualization and virtual screening in molecular property spaces
A Klenner , M Reutlinger , G Schneider
Journal of Cheminformatics 3 ( 1) 8
2011
Taspase1: unraveling its control mechanisms
S Sabiani , T Geppert , G Schneider , T Dingermann
Klinische Padiatrie 222 ( 03)
2010
The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5‐lipoxygenase products
L Fischer , M Hornig , C Pergola , N Meindl
British Journal of Pharmacology 152 ( 4) 471 -480
58
2007
Neural networks are useful tools for drug design
G Schneider
Neural Networks 13 ( 1) 15 -16
94
2000
Molecular similarity for machine learning in drug development
M Rupp , E Proschak , G Schneider
Chemistry Central Journal 2 ( 1) 10
3
2008
Virtual screening for PPAR-gamma ligands using the ISOAK molecular graph kernel and gaussian processes
T Schroeter , M Rupp , K Hansen , K-R Müller
Chemistry Central Journal 3 ( 1) 15
1
2009
SQUIRRELnovo: de novo design of a PPARα agonist by bioisosteric replacement
E Proschak , K Sander , H Zettl , Y Tanrikulu
Chemistry Central Journal 3 ( 1) 1 -1
5
2009
Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor
B Hofmann , CB Rödl , AS Kahnt , TJ Maier
British Journal of Pharmacology 165 ( 7) 2304 -2313
11
2012
Fuzzy virtual ligands for virtual screening
M Löwer , Y Tanrikulu , M Weisel , G Schneider
Chemistry Central Journal 3 ( 1) 63
2009
PocketGraph: graph representation of binding site volumes
M Weisel , J Kriegl , G Schneider
Chemistry Central Journal 3 ( 1) 66
2
2009
Identification of Plk1 type II inhibitors by structure-based virtual screening
S Keppner , E Proschak , G Schneider , B Spänkuch
Chemistry Central Journal 3 ( 1) 65
2009
Virtual chemical reactions for drug design
F Reisen , M Hartenfeller , E Proschak , G Schneider
Chemistry Central Journal 3 ( 1) 68
2009
Pseudoreceptor-based pocket selection in a molecular dynamics simulation of the histamine H4 receptor
T Werner , T Geppert , Y Tanrikulu , E Proschak
Chemistry Central Journal 3 ( 1) 74
2009
Perspectives from Medicinal Chemistry
PLA Popelier , NA Meanwell , M Gastreich , M Rarey
In: N. Brown, editor(s). Bioisosteres in Medicinal Chemistry: Methods and Principles in Medicinal Chemistry. Wiley-VCH; 2012. p. 203-216. 54 217 -230
2
2012